Journey Medical (DERM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DERM Annual Balance Sheets →
Tracking balance sheet results across Journey Medical to Jun 30 2025 helps illustrate how Jun 30 2026's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent25.64
Cash & Short-term Investments25.00
Accounts receivable36.25
Inventories8.16
Prepaid Expense And Other Assets Current2.74
Total Current Assets72.78
Intangible Assets25.51
Other Assets, Noncurrent0.07
Operating Lease Right Of Use Asset0.09
Total Assets98.36
Liabilities
Accounts Payable, Current AC8.05
Accrued Liabilities, Current31.83
Long-term Debt, Current Maturities LO5.00
Other Liabilities, Current0.89
Accrued Income Taxes, Current TA0.00
Total Current Liabilities45.77
Long-term debt25.47
Convertible Notes Payable, Noncurrent LO0.78
Total Long-term Debt26.25
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.09
Total Liabilities66.24
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock133.11
Retained Earnings / Accumulated Deficit-101.00
Other Equity0.00
Common Stockholder's Equity32.11
Total Stockholder's Equity32.11
Liabilities & Stockholder's Equity98.36
4 historic quarters locked

Sign in to unlock the full Journey Medical balance sheet history.

About Journey Medical Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-094948

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.